<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Appl Environ Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Appl Environ Microbiol</journal-id><journal-id journal-id-type="publisher-id">aem</journal-id><journal-title-group><journal-title>Applied and Environmental Microbiology</journal-title></journal-title-group><issn pub-type="ppub">0099-2240</issn><issn pub-type="epub">1098-5336</issn><publisher><publisher-name>American Society for Microbiology</publisher-name><publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40172204</article-id><article-id pub-id-type="pmc">PMC12093960</article-id>
<article-id pub-id-type="publisher-id">aem02114-24</article-id><article-id pub-id-type="doi">10.1128/aem.02114-24</article-id><article-id pub-id-type="publisher-id">aem.02114-24</article-id><article-categories><subj-group subj-group-type="heading"><subject>Environmental Microbiology</subject></subj-group><subj-group subj-group-type="article-attributes"><compound-subject><compound-subject-part content-type="code">spotlight-selection</compound-subject-part><compound-subject-part content-type="label">Spotlight Selection</compound-subject-part></compound-subject></subj-group><subj-group subj-group-type="biological-terms"><compound-subject><compound-subject-part content-type="code">bacteriology</compound-subject-part><compound-subject-part content-type="label">Bacteriology</compound-subject-part></compound-subject></subj-group></article-categories><title-group><article-title><italic toggle="yes">Clostridioides difficile</italic> in feral horse populations in Australia</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4259-4340</contrib-id><name><surname>Hain-Saunders</surname><given-names>Natasza M. R.</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role></contrib><contrib contrib-type="author"><name><surname>Knight</surname><given-names>Daniel R.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Harvey</surname><given-names>Andrea</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Bruce</surname><given-names>Mieghan</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review and editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review and editing</role></contrib><contrib contrib-type="author"><name><surname>Hampson</surname><given-names>Brian A.</given-names></name><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1351-3740</contrib-id><name><surname>Riley</surname><given-names>Thomas V.</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="cor1" ref-type="corresp"/><email>thomas.riley@uwa.edu.au</email></contrib><aff id="aff1"><label>1</label><institution-wrap><institution>Biosecurity and One Health Research Centre, Harry Butler Institute, Murdoch University</institution><institution-id institution-id-type="Ringgold">625323</institution-id></institution-wrap>, <city>Murdoch</city>, <state>Western Australia</state>, <country>Australia</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution>Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre</institution><institution-id institution-id-type="Ringgold">503908</institution-id></institution-wrap>, <city>Nedlands</city>, <state>Western Australia</state>, <country>Australia</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution>School of Biomedical Sciences, The University of Western Australia, Queen Elizabeth II Medical Centre</institution><institution-id institution-id-type="Ringgold">550238</institution-id></institution-wrap>, <city>Nedlands</city>, <state>Western Australia</state>, <country>Australia</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution>Centre for Compassionate Conservation, School of Life Sciences, Faculty of Science, University of Technology Sydney</institution><institution-id institution-id-type="Ringgold">170529</institution-id></institution-wrap>, <city>Broadway</city>, <state>New South Wales</state>, <country>Australia</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution>School of Veterinary Medicine, Murdoch University</institution><institution-id institution-id-type="Ringgold">172103</institution-id></institution-wrap>, <city>Murdoch</city>, <state>Western Australia</state>, <country>Australia</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution>Independent Researcher</institution></institution-wrap>, <city>Brisbane</city>, <country>Australia</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution>School of Medical and Health Sciences, Edith Cowan University</institution><institution-id institution-id-type="Ringgold">204605</institution-id></institution-wrap>, <city>Joondalup</city>, <state>Western Australia</state>, <country>Australia</country></aff></contrib-group><contrib-group><contrib contrib-type="editor"><role>Editor</role><name><surname>Vives</surname><given-names>Martha</given-names></name><aff><institution-wrap><institution>Universidad de los Andes</institution></institution-wrap>, <city>Bogot&#x000e1;</city>, <country>Colombia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to Thomas V. Riley, <email xlink:href="mailto:thomas.riley@uwa.edu.au">thomas.riley@uwa.edu.au</email></corresp><fn fn-type="COI-statement"><p>The authors declare no conflict of interest.</p></fn></author-notes><pub-date publication-format="electronic" date-type="collection"><month>5</month><year>2025</year></pub-date><pub-date date-type="pub" publication-format="electronic"><day>02</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>02</day><month>4</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>91</volume><issue>5</issue><elocation-id>e02114-24</elocation-id><history>
<date date-type="received"><day>25</day><month>10</month><year>2024</year></date>
<date date-type="accepted"><day>14</day><month>2</month><year>2025</year></date>
</history><permissions><copyright-statement>Copyright &#x000a9; 2025 Hain-Saunders et al.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Hain-Saunders et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-04-02"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="aem.02114-24.pdf"/><abstract abstract-type="primary"><title>ABSTRACT</title><p><italic toggle="yes">Clostridioides difficile</italic> is a known cause of diarrhea and colitis in human and non-human animals. While <italic toggle="yes">C. difficile</italic> is regularly isolated from domesticated horses, little is known about its prevalence in wild or feral populations. In Australia, the horse population encompasses a mix of both domesticated and feral animals, with the feral population of 400,000 estimated to be the largest in the world. This study investigated the presence and characteristics of <italic toggle="yes">C. difficile</italic> in Australian feral horses and evaluated their potential as a source or reservoir of <italic toggle="yes">C. difficile</italic> in the wider community. Fecal samples (<italic toggle="yes">n</italic> = 380) were collected from free-roaming feral horses from five Australian jurisdictions and cultured for <italic toggle="yes">C. difficile</italic>. Isolates were characterized by PCR ribotyping and toxin profiling. Antimicrobial susceptibility testing was performed for fidaxomicin, vancomycin, metronidazole, rifaximin, clindamycin, erythromycin, amoxicillin-clavulanate, moxifloxacin, meropenem, and tetracycline. <italic toggle="yes">C. difficile</italic> was isolated from 45 of the 380 samples (11.8%)&#x02014;one-third of that seen in recent studies on Australian domesticated horses but consistent with wild animal species worldwide. Forty ribotypes (RTs) were identified, 28 of which (70%) were novel; other RTs had been previously reported in humans, livestock, and soils. Eighteen toxigenic <italic toggle="yes">C. difficile</italic> strains were isolated, of which eight contain binary toxin genes. Strains were largely susceptible to the antimicrobial agents tested. This investigation provides preliminary information on <italic toggle="yes">C. difficile</italic> in feral horses in Australia and allows a comparison with their domestic counterparts. The findings support the hypothesis that all horse feces represent a potential source of <italic toggle="yes">C. difficile</italic> in the community.</p><sec><title>IMPORTANCE</title><p><italic toggle="yes">Clostridioides difficile</italic> poses an ongoing threat to healthcare in the community, with increasing evidence of transmission outside the hospital setting. In keeping with a One Health model of dispersion, investigations into this microorganism within the wider environment are vital to understanding this evolving epidemiology. Australia has the biggest population of feral horses in the world, and this study of <italic toggle="yes">C. difficile</italic> in feral horses provides insight into the role of non-domesticated animals in the dissemination of <italic toggle="yes">C. difficile</italic>. Examination of prevalence and characterization of isolates provides a baseline for evaluating the effect of antimicrobials and other factors associated with domestication on equine <italic toggle="yes">C. difficile</italic> infection.</p></sec></abstract><kwd-group><title>KEYWORDS</title><kwd><italic toggle="yes">Clostridioides difficile</italic></kwd><kwd><italic toggle="yes">C. difficile</italic></kwd><kwd>horse</kwd><kwd>One Health</kwd></kwd-group><funding-group specific-use="FundRef"><award-group award-type="grant" id="award-1"><funding-source>
<institution-wrap><institution>DHAC | National Health and Medical Research Council (NHMRC)</institution></institution-wrap>
</funding-source><award-id>APP1138257</award-id><principal-award-recipient>
<name><surname>Knight</surname><given-names>Daniel R.</given-names></name>
</principal-award-recipient></award-group></funding-group><counts><count count="0" count-type="supplementary-material"/><count count-type="authors" count="6"/><fig-count count="6"/><table-count count="1"/><ref-count count="62"/><page-count count="13"/><word-count count="6748"/></counts><custom-meta-group><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p><italic toggle="yes">Clostridioides</italic> (<italic toggle="yes">Clostridium</italic>) <italic toggle="yes">difficile</italic> is a gram-positive anaerobic bacillus that causes diarrhea and colitis in human and non-human animals. As a spore-forming bacterium, the ability of <italic toggle="yes">C. difficile</italic> to persist for long periods in the environment and resist common bactericidal agents, such as alcohol, creates unique challenges for disease prevention and control (<xref rid="B1" ref-type="bibr">1</xref>). Furthermore, increasing antimicrobial resistance (AMR), an epidemiological shift in human disease toward infection in the community, and mounting evidence of zoonotic links further highlight the need for more rigorous investigation beyond traditional sources (<xref rid="B2" ref-type="bibr">2</xref><xref rid="B3" ref-type="bibr">&#x02013;</xref><xref rid="B5" ref-type="bibr">5</xref>).</p><p>In horses, <italic toggle="yes">C. difficile</italic> is a known cause of toxin-mediated gastrointestinal disease, impacting both animal welfare and the financial integrity of equine industries. Transmission is by the fecal&#x02013;oral route with impact ranging from asymptomatic carriage to diarrhea, necrotizing enteritis, and associated complications resulting in death (<xref rid="B6" ref-type="bibr">6</xref>). As hindgut fermenters, horses are sensitive to disruption of gut microflora and can show a rapid decline when infected (<xref rid="B7" ref-type="bibr">7</xref>). Mortality rates of confirmed equine <italic toggle="yes">C. difficile</italic> infection (CDI) cases range between 26% and 80% (<xref rid="B8" ref-type="bibr">8</xref><xref rid="B9" ref-type="bibr">&#x02013;</xref><xref rid="B10" ref-type="bibr">10</xref>). In Australia, recent studies reported the presence of <italic toggle="yes">C. difficile</italic> in 31&#x02013;38% of domestic horses, with genetic analysis also identifying clonal strains between horse and human populations (<xref rid="B11" ref-type="bibr">11</xref>). Despite this, investigations into feral and non-domestic equine populations are lacking.</p><p>Australia has the largest population of feral horses (often called brumbies) in the world, comprising an estimated 400,000 feral horses, with origins dating back to the early 1800s (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B13" ref-type="bibr">13</xref>). Distribution extends to all Australian mainland jurisdictions, encompassing a variety of habitats from semi-arid plains through to tropical grasslands and sub-alpine forests (<xref rid="B14" ref-type="bibr">14</xref>). Home ranges for feral horse social groups span between 30 and 70 km<sup>2</sup>, making the potential for dissemination of infectious agents significant and far-reaching (<xref rid="B15" ref-type="bibr">15</xref>). Much of these areas extend through Australia&#x02019;s vast open pastoral areas, creating further dispersal risk at the wildlife&#x02013;livestock&#x02013;human interface through shared water sources and environment.</p><p>Investigations into <italic toggle="yes">C. difficile</italic> in wild and feral animals can help to establish a broader understanding of disease epidemiology as well as provide insights into the evolution and ecology of the bacterial species (<xref rid="B16" ref-type="bibr">16</xref>). Remote animal populations also provide a basis for comparison as subjects with limited exposure to suspected risk factors such as antimicrobials and the hospital environment. It should be noted here that the terms &#x0201c;wild&#x0201d; and &#x0201c;feral&#x0201d; in relation to animals can be variably interpreted with no international standards for terminology. For the purposes of this study, &#x0201c;wild&#x0201d; is defined as a non-domesticated animal, which is indigenous to the region, and the term &#x0201c;feral&#x0201d; as a free-roaming, self-sustaining, non-indigenous animal (whether it be an individual transitioned from domestication or one of its descendants).</p><p>This study aimed to investigate the epidemiology of <italic toggle="yes">C. difficile</italic> in Australian feral horse populations, to identify points of comparison with their domestic counterparts, and to evaluate their potential as a source or reservoir for disease dissemination.</p></sec><sec sec-type="results" id="s2"><title>RESULTS</title><sec id="s2-1"><title>Epidemiology</title><p>Overall, <italic toggle="yes">C. difficile</italic> was isolated from 45 of the 380 feral horse fecal samples (11.8%, 95% CI: 9.0&#x02013;15.5%). Recovery at individual sampling sites, however, varied considerably (range, 0&#x02013;33.3%). The proportion of samples with <italic toggle="yes">C. difficile</italic> in the Northern Territory (3.0%) was lower than Western Australia (16.4%; <italic toggle="yes">P</italic> = 0.002) and New South Wales/Victoria (15.1%; <italic toggle="yes">P</italic> = 0.002) with no difference between other jurisdictions. <xref rid="T1" ref-type="table">Table 1</xref> summarizes the proportions of <italic toggle="yes">C. difficile</italic> isolated from Australian feral horses for the collection sites and jurisdictions.</p><table-wrap position="float" id="T1"><label>TABLE 1</label><caption><p><italic toggle="yes">C. difficile</italic> proportion positive isolated from feral horse feces by location</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/></colgroup><thead><tr><th align="left" valign="top" colspan="1" rowspan="1">Sample origin</th><th align="left" valign="top" colspan="1" rowspan="1">Samples (<italic toggle="yes">n</italic>)</th><th align="left" valign="top" colspan="1" rowspan="1"><italic toggle="yes">C. difficile</italic>-positive samples</th><th align="left" valign="top" colspan="1" rowspan="1">Proportion positive (%)</th><th align="left" valign="top" colspan="1" rowspan="1">95% CI</th></tr></thead><tbody><tr><td align="left" valign="top" colspan="1" rowspan="1">Western Australia</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>73</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>12</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>16.4%</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">(<bold>9.7%; 26.6</bold>)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Ashburton</td><td align="left" valign="top" colspan="1" rowspan="1">24</td><td align="left" valign="top" colspan="1" rowspan="1">2</td><td align="left" valign="top" colspan="1" rowspan="1">8.3%</td><td align="left" valign="top" colspan="1" rowspan="1">(2.3%; 25.9%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Meekatharra</td><td align="left" valign="top" colspan="1" rowspan="1">9</td><td align="left" valign="top" colspan="1" rowspan="1">0</td><td align="left" valign="top" colspan="1" rowspan="1">0.0%</td><td align="left" valign="top" colspan="1" rowspan="1">(0.0%; 29.9%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Lake Logue</td><td align="left" valign="top" colspan="1" rowspan="1">18</td><td align="left" valign="top" colspan="1" rowspan="1">6</td><td align="left" valign="top" colspan="1" rowspan="1">33.3%</td><td align="left" valign="top" colspan="1" rowspan="1">(16.3%; 56.2%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Cape Arid</td><td align="left" valign="top" colspan="1" rowspan="1">10</td><td align="left" valign="top" colspan="1" rowspan="1">2</td><td align="left" valign="top" colspan="1" rowspan="1">20.0%</td><td align="left" valign="top" colspan="1" rowspan="1">(5.7%; 50.9%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Merivale</td><td align="left" valign="top" colspan="1" rowspan="1">12</td><td align="left" valign="top" colspan="1" rowspan="1">2</td><td align="left" valign="top" colspan="1" rowspan="1">16.7%</td><td align="left" valign="top" colspan="1" rowspan="1">(4.7%; 44.8%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Queensland</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>21</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>2</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>9.5%</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">(<bold>2.6%; 28.9%</bold>)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Northern Territory</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>101</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>3</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>3.0%</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">(<bold>1.0%; 8.4%</bold>)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">New South Wales/Victoria</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>185</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>28</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>15.1%</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">(<bold>10.7%; 21.0%</bold>)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Blue Mountains</td><td align="left" valign="top" colspan="1" rowspan="1">25</td><td align="left" valign="top" colspan="1" rowspan="1">6</td><td align="left" valign="top" colspan="1" rowspan="1">24.0%</td><td align="left" valign="top" colspan="1" rowspan="1">(11.5%; 43.4%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Bogong High Plains</td><td align="left" valign="top" colspan="1" rowspan="1">7</td><td align="left" valign="top" colspan="1" rowspan="1">0</td><td align="left" valign="top" colspan="1" rowspan="1">0.0%</td><td align="left" valign="top" colspan="1" rowspan="1">(0.0%; 35.4%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Cooleman</td><td align="left" valign="top" colspan="1" rowspan="1">73</td><td align="left" valign="top" colspan="1" rowspan="1">14</td><td align="left" valign="top" colspan="1" rowspan="1">19.2%</td><td align="left" valign="top" colspan="1" rowspan="1">(11.8%; 29.6%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;Cowombat</td><td align="left" valign="top" colspan="1" rowspan="1">54</td><td align="left" valign="top" colspan="1" rowspan="1">4</td><td align="left" valign="top" colspan="1" rowspan="1">7.4%</td><td align="left" valign="top" colspan="1" rowspan="1">(2.9%; 17.5%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">&#x02003;South Kosciuszko N.P.</td><td align="left" valign="top" colspan="1" rowspan="1">26</td><td align="left" valign="top" colspan="1" rowspan="1">4</td><td align="left" valign="top" colspan="1" rowspan="1">15.4%</td><td align="left" valign="top" colspan="1" rowspan="1">(6.1%; 33.5%)</td></tr><tr><td align="left" valign="top" colspan="1" rowspan="1">Total</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>380</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>45</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">
<bold>11.8%</bold>
</td><td align="left" valign="top" colspan="1" rowspan="1">(<bold>8.9%; 15.7%</bold>)</td></tr></tbody></table></table-wrap><p>In total, 40 different <italic toggle="yes">C. difficile</italic> ribotypes (RTs) were identified across all horse samples. This comprised a combination of novel (<italic toggle="yes">n</italic> = 28) and previously described (<italic toggle="yes">n</italic> = 12) RTs, including RTs 014/020 and RT 075, which have been reported in human CDI. Some of the other RTs had been reported also in Australian root vegetables, soils, and water. <xref rid="F1" ref-type="fig">Figure 1</xref> shows the RT frequencies of all <italic toggle="yes">C. difficile</italic> strains isolated and an indication of other sources of similar strains.</p><fig position="float" fig-type="figure" id="F1"><label>Fig 1</label><caption><p>Characteristics of <italic toggle="yes">C. difficile</italic> isolated from feces of 45 Australian feral horses. Internationally recognized strains prefixed &#x0201c;RT&#x0201d; (<italic toggle="yes">n</italic> = 3) and locally identified strains prefixed &#x0201c;QX&#x0201d; (<italic toggle="yes">n</italic> = 10). Toxigenic strains contain at least one of the toxin genes <italic toggle="yes">tcdA</italic> (A+), <italic toggle="yes">tcdB</italic> (B+), or <italic toggle="yes">cdtA/B</italic> (CDT+). Novel strain data points titled &#x0201c;Unique&#x0201d; comprise the total number of novel strains in this category, which were only isolated once in this study (<italic toggle="yes">n</italic> = 22). Novel strain data points that are numbered (A, B, C&#x02026;) indicate individual novel strains with a frequency of more than one (<italic toggle="yes">n</italic> = 10).</p></caption><graphic xlink:href="aem.02114-24.f001" position="float"><alt-text>The bar graph depicts the frequency of ribotypes as toxigenic or non-toxigenic with presence in humans, domestic horses, environment, and root vegetables. Novel and known ribotypes exhibit varying distributions with some overlapping across different sources.</alt-text></graphic></fig><p>There were six different toxin gene profiles identified, with frequencies of each outlined in <xref rid="F2" ref-type="fig">Fig. 2</xref>. Forty-two percent of <italic toggle="yes">C. difficile</italic> isolates (<italic toggle="yes">n</italic> = 19) were toxigenic, containing at least one of the toxin genes <italic toggle="yes">tcdA</italic> (A+), <italic toggle="yes">tcdB</italic> (B+), or <italic toggle="yes">cdtA/B</italic> (CDT+). Of these, six strains contained binary toxin genes (five in novel RTs, plus one in RT075), three of which contained binary toxin genes only. In addition, five strains contained the toxin A gene only.</p><fig position="float" fig-type="figure" id="F2"><label>Fig 2</label><caption><p>Toxin gene profiles of <italic toggle="yes">C. difficile</italic> strains isolated from Australian feral horse feces. Toxigenic strains are those which contain at least one of the toxin genes <italic toggle="yes">tcdA</italic> (A+), <italic toggle="yes">tcdB</italic> (B+), or <italic toggle="yes">cdtA/B</italic> (CDT+).</p></caption><graphic xlink:href="aem.02114-24.f002" position="float"><alt-text>The stacked bar graph depicts the frequency of toxin types across NT, QLD, WA, and NSW/VIC. A&#x02212;B&#x02212;CDT&#x02212; has the highest frequency, followed by A+B+CDT&#x02212;. Other toxin types exhibit lower frequencies, with variations across regions.</alt-text></graphic></fig></sec><sec id="s2-2"><title>Antimicrobial susceptibility testing (AST)</title><p>MIC distributions for the 10 antimicrobial agents tested against the <italic toggle="yes">C. difficile</italic> strains isolated from Australian feral horses are shown in <xref rid="F3" ref-type="fig">Fig. 3</xref>. These strains were largely susceptible to the 10 antimicrobial agents. Resistance to four agents was identified, comprising clindamycin (<italic toggle="yes">n</italic> = 16, 36%), erythromycin (<italic toggle="yes">n</italic> = 1, 2%), tetracycline (<italic toggle="yes">n</italic> = 1, 2%), and vancomycin (<italic toggle="yes">n</italic> = 2; 4%), the latter of which is used in the treatment of human CDI. Susceptibility to fidaxomicin, also used to treat human CDI, remained high. All strains were susceptible to metronidazole (MIC &#x0003c;2 mg/L), the preferred agent for the treatment of CDI in animals. One Western Australian strain (LL011) displayed resistance to three (clindamycin, erythromycin, and tetracycline), deeming it multi-drug resistant.</p><fig position="float" fig-type="figure" id="F3"><label>Fig 3</label><caption><p>MIC distributions for 10 antimicrobial agents against 45 Australian feral horse strains of <italic toggle="yes">C. difficile</italic>. Breakpoints are indicated with green (susceptible) and red (resistant) vertical lines. AMC, amoxicillin/clavulanate; CLI, clindamycin; ERY, erythromycin; FDX, fidaxomicin; MEM, meropenem; MTZ, metronidazole; MXF, moxifloxacin; RFX, rifaximin; VAN, vancomycin.</p></caption><graphic xlink:href="aem.02114-24.f003" position="float"><alt-text>Histograms depict minimum inhibitory concentration distributions for antibiotics. MIC values at the 20th, 50th, and 90th percentiles and geometric means are included. Vertical lines indicate interpretive breakpoints. Strain counts vary across antibiotics.</alt-text></graphic></fig><p><xref rid="F4" ref-type="fig">Figure 4</xref> presents a comparison of the percentage of AMR in feral horse <italic toggle="yes">C. difficile</italic> strains compared to domestic horse data sets described in Hain-Saunders et al. (<xref rid="B11" ref-type="bibr">11</xref>). Resistance in domestic horse isolates appeared consistently higher than that in feral horses except for vancomycin. Despite this, the difference between the two populations was only statistically significant for rifaximin (<italic toggle="yes">P</italic> = 0.02).</p><fig position="float" fig-type="figure" id="F4"><label>Fig 4</label><caption><p>Comparison of resistance to 10 antimicrobial agents in strains of <italic toggle="yes">C. difficile</italic> isolated from Australian feral (<italic toggle="yes">n</italic> = 45) and domestic (<italic toggle="yes">n</italic> = 160) horses. *Agents currently recommended for the treatment of <italic toggle="yes">C. difficile</italic> in humans (fidaxomicin, metronidazole, and vancomycin) and horses (metronidazole only).</p></caption><graphic xlink:href="aem.02114-24.f004" position="float"><alt-text>The bar graph depicts antibiotic resistance percentages in feral and domestic groups across different antibiotic classes. Clindamycin exhibits the highest percentage of resistance. Other antibiotics depict lower percentages, with variation between groups.</alt-text></graphic></fig></sec><sec id="s2-3"><title>Atypical phenotype</title><p>One noteworthy strain isolated from feral horse feces produced white colonies on CHROMID <italic toggle="yes">C. difficile</italic> agar (bioM&#x000e9;rieux). Typically, growth of <italic toggle="yes">C. difficile</italic> on CHROMID <italic toggle="yes">C. difficile</italic> agar gives black colonies due to esculin hydrolysis. However, despite verification as <italic toggle="yes">C. difficile</italic> by MALDI-TOF, microscopy, and phenotypic characteristics on horse blood agar, colonies of New South Wales strain H285 demonstrated a white, ground-glass appearance on CHROMID as shown in <xref rid="F5" ref-type="fig">Fig. 5</xref> compared to the typical black colonies of a control strain. This non-toxigenic strain appeared to be a novel RT.</p><fig position="float" fig-type="figure" id="F5"><label>Fig 5</label><caption><p>Images showing (<bold>A</bold>) the typical appearance of <italic toggle="yes">C. difficile</italic> growth on CHROMID <italic toggle="yes">C. difficile</italic> agar (bioM&#x000e9;rieux) after 48 h with black colonies of control strain <italic toggle="yes">C. difficile</italic> RT078 and (<bold>B</bold>) the growth of esculin hydrolysis-negative <italic toggle="yes">C. difficile</italic> strain H285 (isolated in this study) after 48 h growth with white colonies on CHROMID.</p></caption><graphic xlink:href="aem.02114-24.f005" position="float"><alt-text>Bacterial colonies grown on selective agar plates. One plate contains black colonies, while the other has white colonies. Colony morphology differs between plates, depicting variations in bacterial strains or growth conditions.</alt-text></graphic></fig></sec></sec><sec sec-type="discussion" id="s3"><title>DISCUSSION</title><p>This study is the first known investigation into <italic toggle="yes">C. difficile</italic> in feral horse populations. The data provide valuable information on the prevalence of <italic toggle="yes">C. difficile</italic> in animals at the wildlife&#x02013;livestock&#x02013;human interface as well as baseline data for evaluating the effects of antimicrobials and other domestication factors on <italic toggle="yes">C. difficile</italic> prevalence and characteristics.</p><sec id="s3-1"><title><italic toggle="yes">C. difficile</italic> isolation</title><p>The overall recovery of <italic toggle="yes">C. difficile</italic> in feral horse feces (11.8%) was consistent with <italic toggle="yes">C. difficile</italic> prevalence identified in wild mammal populations such as polar bears (16.8%), wild bears (15%), and migratory bats (19.4%) (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B17" ref-type="bibr">17</xref>). The consistency seen in these limited subsets is suggestive of an underlying reservoir in wild and feral populations. The considerable variation in the prevalence of <italic toggle="yes">C. difficile</italic> seen between collection sites was similar to that seen in domestic horse populations and may reflect transient colonization with <italic toggle="yes">C. difficile,</italic> although site and jurisdictional biogeographical variations should be considered. Such variability has been reported previously in horse longitudinal studies and in other livestock populations and has been attributed to short-term stress factors such as feed changes, transportation, and seasonal changes, which can lead to a disruption to the natural gut flora (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B18" ref-type="bibr">18</xref><xref rid="B19" ref-type="bibr">&#x02013;</xref><xref rid="B20" ref-type="bibr">20</xref>).</p><p>Investigations into <italic toggle="yes">C. difficile</italic> in horses to date have focused on companion animals and racehorses, with reported <italic toggle="yes">C. difficile</italic> carriage ranging between 0 and 14% in healthy adult horses, 5 and 63% in diarrheic horses, and 16 and 29% in foals (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B21" ref-type="bibr">21</xref><xref rid="B22" ref-type="bibr">&#x02013;</xref><xref rid="B25" ref-type="bibr">25</xref>). This categorized approach to prevalence reporting reflects the risk factors associated with <italic toggle="yes">C. difficile</italic>. Age and health status are two major factors in disease prevalence and transmission. Young human and non-human animals consistently show high rates of colonization with <italic toggle="yes">C. difficile</italic>, often attributed to their developing gut microbiome (<xref rid="B25" ref-type="bibr">25</xref>). In the current study, the blind testing of feral horse fecal samples with limited knowledge of the host, particularly health status, created some difficulties in analysis and the extent to which these factors impacted the results. Collection of whole pellets of horse feces from the feral horses, however, indicated that these horses were not diarrheic at the time of sampling.</p><p><italic toggle="yes">C. difficile</italic> recovery from Australian feral horse feces (12%) was significantly less than from Australian domestic horses with (38%, <italic toggle="yes">P</italic> &#x0003c; 0.001) and without (31%, <italic toggle="yes">P</italic> &#x0003c; 0.001) gastrointestinal signs using the same experimental approach and methods (<xref rid="B11" ref-type="bibr">11</xref>). While the higher population density of domesticated horses and proximity to other animals and humans increases the potential for dispersal, the use of antimicrobials in the domestic populations is likely to be the most important factor. It has been long established that antimicrobial use is a factor influencing CDI in both humans and animals, through the disruption of the gut microbiota (<xref rid="B26" ref-type="bibr">26</xref>). The role of the existing microbiota in wider disease establishment is becoming increasingly apparent (<xref rid="B27" ref-type="bibr">27</xref>). In the case of <italic toggle="yes">C. difficile</italic>, it is thought that commensal bacteria compete for nutrients and adhesion sites. The use of antimicrobials not only disrupts this natural barrier, but studies have also suggested that certain antimicrobials may increase adhesin and toxin gene expression, leading to increased pathogenicity (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>).</p><p>Antimicrobials are widely used in domesticated horse populations, one of the most common being ceftiofur (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Ceftiofur significantly disrupts commensal bacterial counts in the horse hindgut for at least 1 week after administration, with the appearance of <italic toggle="yes">C. difficile</italic> within 24 h of administration (<xref rid="B32" ref-type="bibr">32</xref>). Despite a national action plan calling for the urgent establishment of antimicrobial stewardship programs in veterinary practices across Australia, implementation remains limited (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>).</p></sec><sec id="s3-2"><title>Toxin profile variability</title><p>Overall, 42% of all strains isolated in this study were toxigenic. This appears comparatively lower than previous investigations into <italic toggle="yes">C. difficile</italic> in horses and other livestock (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B36" ref-type="bibr">36</xref>). The reasons behind this lower toxigenicity were not clear; however, the absence of known diarrheic samples in this study likely played a role.</p><p>Although symptomatic infection is related to the presence of toxin-forming strains of <italic toggle="yes">C. difficile</italic>, it has been shown experimentally that non-toxigenic strains can acquire toxin genes through horizontal gene transfer (<xref rid="B37" ref-type="bibr">37</xref><xref rid="B38" ref-type="bibr">&#x02013;</xref><xref rid="B39" ref-type="bibr">39</xref>). While the frequency at which this occurs is unknown, horizontal gene transfer is thought to have been a factor in the emergence of hypervirulent strains in recent times such as RT 027 (<xref rid="B40" ref-type="bibr">40</xref>). Epidemiological studies of both toxigenic and non-toxigenic strains therefore remain critical for effective surveillance of emerging strains.</p><p>The isolation of toxigenic strains containing only toxin A or binary toxin genes in this study is also of great concern. Virulence investigations of such strains in hamster models have reported both severe disease and death; however, their discovery in clinical disease is relatively recent (<xref rid="B41" ref-type="bibr">41</xref>). The ability of these mono-toxin strains to evade certain laboratory tests needs to be considered in the use and development of <italic toggle="yes">C. difficile</italic> laboratory protocols and testing schemes (<xref rid="B42" ref-type="bibr">42</xref>). While two-step testing is recommended in both animal and human <italic toggle="yes">C. difficile</italic> disease diagnosis, this has yet to gain widespread adoption in equine veterinary practice (<xref rid="B43" ref-type="bibr">43</xref><xref rid="B44" ref-type="bibr">&#x02013;</xref><xref rid="B45" ref-type="bibr">45</xref>). Inconsistency and a lack of standardization in diagnostic protocols have been reported as being a major hindrance to the clinical diagnosis of horse colitis cases and understanding of the equine gut microbiota (<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>). These issues, combined with insufficient testing regimes, pose a significant and ongoing risk to both equine and human health.</p></sec><sec id="s3-3"><title>Diversity of RT patterns</title><p>Only 13 of the 45 <italic toggle="yes">C</italic>. <italic toggle="yes">difficile</italic>-positive samples&#x02019; RTs were previously identified, having been reported in lawns, vegetables, and humans (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>). The remaining 32 samples (71%) contained RTs which were novel to our laboratory. As investigations into community-associated CDI gain momentum and exploration into environmental sources of <italic toggle="yes">C. difficile</italic> continues, it is likely more novel RTs will be identified, particularly in remote regions. The high diversity of RTs and the minimal overlap between isolates from feral horses compared to domestic horse populations are not surprising. Given the remote locations of the feral populations, this likely indicates that regional strains may have evolved in isolation from the more common strains circulating in domesticated populations and urban settings. Although feral horses are not native to Australia, many of the populations sampled have been established within the remote regions since the early 19th century (<xref rid="B15" ref-type="bibr">15</xref>), allowing time for these unique strains to develop and disperse through local populations. Evidence for such localized evolution has come to light in recent genomic investigations of clade 5 ST11 strains, which proposed the coevolution of the closely related RT 078 and RT 126, occupying the same niche within different geographical regions, and possibly explaining the distinct absence of the former within Australia (<xref rid="B4" ref-type="bibr">4</xref>).</p><p>This may also be the case for the identification of isolates with atypical characteristics as seen with the isolation of an esculin hydrolysis negative strain. Esculin hydrolysis is a biochemical characteristic of <italic toggle="yes">C. difficile</italic> exploited in some differential agar, including CHROMID used in this current study. On these plates, the hydrolysis of esculin within the agar creates a black pigmentation and results in <italic toggle="yes">C. difficile</italic> strains appearing as black colonies (<xref rid="B50" ref-type="bibr">50</xref>). Isolates that do not possess this characteristic appear as white colonies on CHROMID and therefore bypass the differential function of the agar. There have been reports of esculin hydrolysis-negative <italic toggle="yes">C. difficile</italic> RTs in clinical settings (<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>) as well as in soils (<xref rid="B53" ref-type="bibr">53</xref>). Although the isolate identified in the current study was non-toxigenic, this presents an expanding issue in the emergence of esculin hydrolysis-negative <italic toggle="yes">C. difficile</italic> strains and concern for false-negative results.</p></sec><sec id="s3-4"><title>Antimicrobial susceptibility testing</title><p>Antimicrobial susceptibility results were similar to studies of domestic horses in Australia, showing a high proportion of clindamycin resistance and limited resistance to erythromycin and tetracycline. Interestingly, two feral horse strains from different geographical regions were resistant to vancomycin with MICs of 4 mg/L (breakpoint &#x0003e;2 mg/L), an agent used in the treatment of CDI in humans. Mutation in the VanSCD sensor histidine kinase and VanRCD response regulator of the vanG operon-like gene cluster vanGCD has been proposed as the primary mechanism for vancomycin resistance in <italic toggle="yes">C. difficile</italic>, although individual causes were not explored in this study (<xref rid="B54" ref-type="bibr">54</xref>).</p><p>Given the limited exposure of feral animals to antimicrobial agents, however, this likely indicates the existence of reservoirs of resistance due to spontaneous mutation (as opposed to that induced by exposure) outside domestic and clinical settings and further supports the need for a more formalized means of AMR surveillance and antimicrobial use monitoring in animal populations in Australia. For an organism that the US CDC named in the top five posing an urgent AMR threat to public health, complacency can no longer be accepted (<xref rid="B55" ref-type="bibr">55</xref>).</p></sec><sec id="s3-5"><title>Conclusion</title><p>The diversity of strains and unique characteristics identified in this study indicate that further investigation into <italic toggle="yes">C. difficile</italic> outside of traditional settings is required. While diagnostic testing focuses on the mere presence of disease, an urgent need for molecular typing as an ongoing surveillance measure is becoming increasingly apparent. The findings in this study support the hypothesis that horses&#x02014;whether feral or domestic&#x02014;represent a possible source/reservoir for <italic toggle="yes">C. difficile</italic> dispersion through interactions with humans, other animals, and the environment. This highlights the need for a holistic &#x0201c;One Health&#x0201d; approach to <italic toggle="yes">C. difficile</italic> research, and prevention and control of disease.</p></sec></sec><sec sec-type="materials|methods" id="s4"><title>MATERIALS AND METHODS</title><sec id="s4-1"><title>Study population and sample collection</title><p>Fecal samples (<italic toggle="yes">n</italic> = 380) were collected between December 2016 and December 2020 from 11 locations across five Australian jurisdictions, including the States of Western Australia, Queensland, New South Wales and Victoria, and the Northern Territory (<xref rid="F6" ref-type="fig">Fig. 6</xref>). Western Australian and Northern Territory collection sites were identified in collaboration with brumby associations, agricultural landowners, and traditional landowners based on known population territories and reports of recent sightings. Where feces were fully formed, whole individual fecal pellets were collected to reduce contamination of the internal fecal matter from the environment, and, where allowed, environmental samples were also taken close to where the fecal samples were collected to assess for potential contamination. In Queensland, samples were collected from feral horses during trapping and relocation programs, while New South Wales and Victorian samples were taken during a population ecology, health, and welfare survey with detailed sample collection procedures further outlined by Harvey et al. (<xref rid="B56" ref-type="bibr">56</xref>). New South Wales and Victorian data are combined in data comparisons reported here due to the close proximity of some sampling sites in these jurisdictions.</p><fig position="float" fig-type="figure" id="F6"><label>Fig 6</label><caption><p>Feral horse fecal sample collection sites across Australia. Map data &#x000a9; 2019 GBRMPA, Google.</p></caption><graphic xlink:href="aem.02114-24.f006" position="float"><alt-text>The map depicts locations across Australia, including Ashburton, Meekatharra, Lake Logue, Merivale, Cape Arid, Kings Canyon, Mereenie Region, Caldervale, Blue Mountains, Cooleman, Cowombat, South Kosciuszko, and Bogong High Plains.</alt-text></graphic></fig></sec><sec id="s4-2"><title>Culture</title><p>Fecal samples were cultured for <italic toggle="yes">C. difficile</italic> using previously described methods (<xref rid="B11" ref-type="bibr">11</xref>). Briefly, individual fecal pellets were carefully cut on the transverse plane, and a portion was extracted from the core to avoid surface environmental contamination. Approximately 10 g was added to a 90 mL selective brain heart infusion broth supplemented with 5 &#x02009;g/L yeast extract, 1 &#x02009;g/L l-cysteine, 1 &#x02009;g/L taurocholic acid, 250 &#x02009;mg/L cycloserine, and 8 &#x02009;mg/L cefoxitin (BHIB-S) (PathWest Media, Mt Claremont, WA) and incubated with lids loose for 7 days in an A35 anaerobic chamber (Don Whitley Scientific Ltd, Yorkshire, UK) at 35&#x000b0;C with an atmosphere of 80% nitrogen, 10% hydrogen, 10% carbon dioxide, and a relative humidity of 75%. The cultures were then alcohol shocked at a 1:1 ratio for 1 h to select for spores. A 10 &#x000b5;L aliquot was streaked onto a ChromID <italic toggle="yes">C. difficile</italic> agar plate (bioM&#x000e9;rieux, Marcy-l'&#x000c9;toile, France) and incubated anaerobically for 48 h. Putative <italic toggle="yes">C. difficile</italic> colonies were sub-cultured onto horse blood agar and incubated anaerobically for a further 48 h. <italic toggle="yes">C. difficile</italic> was confirmed by characteristic ground-glass colony appearance, distinct barnyard odor, and chartreuse fluorescence under UV light (~360 nm).</p></sec><sec id="s4-3"><title><italic toggle="yes">C. difficile</italic> characterization</title><p>Multiplex PCR and capillary electrophoresis were used as previously described for ribotyping and toxin gene characterization (<xref rid="B57" ref-type="bibr">57</xref>). RT banding patterns were visualized using QIAxcel ScreenGel software (Qiagen, Venlo, Netherlands). Densitometric curve and band pattern analysis was performed using the Bionumerics v7.1 software package (Applied Maths, Sint-Martens-Latem, Belgium) based on the Dice coefficient and Pearson correlation, and comparison was made with a database of over 10,000 strains of both internationally recognized and local strains. Toxin gene profiles were determined by the presence of <italic toggle="yes">tcdA</italic> (toxin A), <italic toggle="yes">tcdB</italic> (toxin B), and <italic toggle="yes">cdtA</italic> and <italic toggle="yes">cdtB</italic> (binary toxin).</p></sec><sec id="s4-4"><title>AST</title><p>The antimicrobials fidaxomicin, vancomycin, metronidazole, rifaximin, clindamycin, erythromycin, amoxicillin-clavulanate, moxifloxacin, meropenem, and tetracycline were chosen for antimicrobial testing based on their usage in veterinary practice, human healthcare, and CDI treatment and prevention. MICs of these agents were determined using the agar incorporation method described by the Clinical and Laboratory Standards Institute (CLSI) (<xref rid="B58" ref-type="bibr">58</xref>). Clinical breakpoints used for vancomycin and metronidazole were recommended by the European Committee on Antimicrobial Susceptibility Testing (<xref rid="B59" ref-type="bibr">59</xref>), while those for fidaxomicin and rifaximin were proposed by the European Medicines Agency (<xref rid="B60" ref-type="bibr">60</xref>) and O&#x02019;Connor et al. (<xref rid="B61" ref-type="bibr">61</xref>). All other breakpoints were based on CLSI recommendations (<xref rid="B62" ref-type="bibr">62</xref>). MIC50, MIC90, and geometric mean MIC values were calculated for all antimicrobials.</p></sec><sec id="s4-5"><title>Comparative analysis</title><p>Statistical analyses were performed using the Chi-squared test, with a two-tailed <italic toggle="yes">P</italic> value&#x02009;&#x0003c;&#x02009;0.05 considered significant. All comparisons to domestic horse populations utilized data sets established and described in Hain-Saunders et al. (<xref rid="B11" ref-type="bibr">11</xref>).</p></sec></sec></body><back><ack><title>ACKNOWLEDGMENTS</title><p>We acknowledge Anslem Impu, Jr., the traditional owners of the Kings Canyon and Mereenie region, the Central Land Council, and the Northern Territory Government for permitting access to and providing navigation within the region for the collection of feral horse fecal samples for this study.</p><p>N.M.R.H.-S. was supported by a Research and Innovation Strategic Scholarship from Murdoch University.</p></ack><ref-list><title>REFERENCES</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>B&#x000e5;verud</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Gustafsson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Franklin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Asp&#x000e1;n</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gunnarsson</surname>
<given-names>A</given-names></string-name></person-group>. <year>2003</year>. <article-title>Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility</article-title>. <source>Equine Vet J</source>
<volume>35</volume>:<fpage>465</fpage>&#x02013;<lpage>471</lpage>. doi:<pub-id pub-id-type="doi">10.2746/042516403775600505</pub-id><pub-id pub-id-type="pmid">12875324</pub-id>
</mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Khanna</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pardi</surname>
<given-names>DS</given-names></string-name>, <string-name><surname>Aronson</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Kammer</surname>
<given-names>PP</given-names></string-name>, <string-name><surname>Orenstein</surname>
<given-names>R</given-names></string-name>, <string-name><surname>St Sauver</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Harmsen</surname>
<given-names>WS</given-names></string-name>, <string-name><surname>Zinsmeister</surname>
<given-names>AR</given-names></string-name></person-group>. <year>2012</year>. <article-title>The epidemiology of community-acquired Clostridium difficile infection: a population-based study</article-title>. <source>Am J Gastroenterol</source>
<volume>107</volume>:<fpage>89</fpage>&#x02013;<lpage>95</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ajg.2011.398</pub-id><pub-id pub-id-type="pmid">22108454</pub-id>
</mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Slimings</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Armstrong</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Beckingham</surname>
<given-names>WD</given-names></string-name>, <string-name><surname>Bull</surname>
<given-names>AL</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Kennedy</surname>
<given-names>KJ</given-names></string-name>, <string-name><surname>Marquess</surname>
<given-names>J</given-names></string-name>, <string-name><surname>McCann</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Menzies</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>BG</given-names></string-name>, <string-name><surname>Richards</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Smollen</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Tracey</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wilkinson</surname>
<given-names>IJ</given-names></string-name>, <string-name><surname>Wilson</surname>
<given-names>FL</given-names></string-name>, <string-name><surname>Worth</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2014</year>. <article-title>Increasing incidence of Clostridium difficile infection, Australia, 2011-2012</article-title>. <source>Med J Aust</source>
<volume>200</volume>:<fpage>272</fpage>&#x02013;<lpage>276</lpage>. doi:<pub-id pub-id-type="doi">10.5694/mja13.11153</pub-id><pub-id pub-id-type="pmid">24641152</pub-id>
</mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Knight</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Kullin</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Androga</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>Barbut</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Spigaglia</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tateda</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>P-J</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2019</year>. <article-title>Evolutionary and genomic insights into Clostridioides difficile sequence type 11: a diverse zoonotic and antimicrobial-resistant lineage of global one health importance</article-title>. <source>MBio</source>
<volume>10</volume>:<elocation-id>e00446-19</elocation-id>. doi:<pub-id pub-id-type="doi">10.1128/mBio.00446-19</pub-id><pub-id pub-id-type="pmid">30992351</pub-id>
</mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Australian Commission on Safety and Quality in Health Care</collab></person-group>. <year>2023</year>. <article-title>Clostridioides difficile infection data snapshot report: 2020 and 2021</article-title>. <publisher-name>Australian Commission on Safety and Quality in Health Care</publisher-name>. <publisher-loc>Sydney, Australia</publisher-loc></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Arroyo</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Staempfli</surname>
<given-names>HR</given-names></string-name></person-group>. <year>2004</year>. <article-title>Experimental Clostridium difficile enterocolitis in foals</article-title>. <source>J Vet Intern Med</source>
<volume>18</volume>:<fpage>734</fpage>&#x02013;<lpage>738</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1939-1676.2004.tb02613.x</pub-id><pub-id pub-id-type="pmid">15515592</pub-id>
</mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bland</surname>
<given-names>SD</given-names></string-name></person-group>. <year>2016</year>. <article-title>Equine colic: a review of the equine hindgut and colic</article-title>. <source>Vet Sci Develop</source>
<volume>6</volume>. doi:<pub-id pub-id-type="doi">10.4081/vsd.2016.6223</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Arroyo</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Staempfli</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name></person-group>. <year>2007</year>. <article-title>Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea</article-title>. <source>Vet Microbiol</source>
<volume>120</volume>:<fpage>179</fpage>&#x02013;<lpage>183</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2006.10.013</pub-id><pub-id pub-id-type="pmid">17112686</pub-id>
</mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Toxopeus</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Arroyo</surname>
<given-names>L</given-names></string-name></person-group>. <year>2006</year>. <article-title>Clostridium difficile associated diarrhoea in horses within the community: predictors, clinical presentation and outcome</article-title>. <source>Equine Vet J</source>
<volume>38</volume>:<fpage>185</fpage>&#x02013;<lpage>188</lpage>. doi:<pub-id pub-id-type="doi">10.2746/042516406776563369</pub-id><pub-id pub-id-type="pmid">16536390</pub-id>
</mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Uchida-Fujii</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Niwa</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Senoh</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kinoshita</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Mita</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Ueno</surname>
<given-names>T</given-names></string-name></person-group>. <year>2023</year>. <article-title>Clostridioides difficile infection in thoroughbred horses in Japan from 2010 to 2021</article-title>. <source>Sci Rep</source>
<volume>13</volume>:<elocation-id>13099</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/s41598-023-40157-x</pub-id><pub-id pub-id-type="pmid">37567893</pub-id>
</mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hain-Saunders</surname>
<given-names>NMR</given-names></string-name>, <string-name><surname>Knight</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Bruce</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Byrne</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2023</year>. <article-title>Genomic analysis of Clostridioides difficile recovered from horses in western australia</article-title>. <source>Microorganisms</source>
<volume>11</volume>:<elocation-id>1743</elocation-id>. doi:<pub-id pub-id-type="doi">10.3390/microorganisms11071743</pub-id><pub-id pub-id-type="pmid">37512915</pub-id>
</mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><string-name><surname>Dobbie</surname>
<given-names>WR</given-names></string-name>, <string-name><surname>Berman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Braysher</surname>
<given-names>M</given-names></string-name></person-group>. <year>1993</year>. <source>Managing vertebrate pests: feral horses</source>. <publisher-name>Australian Government Publishing Service</publisher-name>, <publisher-loc>Canberra, Australia</publisher-loc>.</mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="confproc">
<person-group person-group-type="author"><string-name><surname>Dawson</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Lane</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Saunders</surname>
<given-names>G</given-names></string-name></person-group>. <conf-name>Proceedings of the National Feral Horse Management Workshop August 2006</conf-name>. <publisher-name>Invasive Animals Cooperative Research Centre</publisher-name>, <publisher-loc>Canberra, ACT, Australia</publisher-loc></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Department of Sustainability, Environment, Water, Population and Communities</collab></person-group>. <year>2016</year>. <article-title>Feral horse (Equus caballus) and feral donkey (Equus asinus)</article-title>. <publisher-loc>Canberra, ACT, Australia</publisher-loc>
<publisher-name>Department of Sustainability, Environment, Water, Population and Communities</publisher-name></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><string-name><surname>Csurhes</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Paroz</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Markula</surname>
<given-names>A</given-names></string-name></person-group>. <year>2016</year>. <article-title>Ferel horses: invasive animal risk assessment</article-title>. <publisher-loc>Queensland, Australia</publisher-loc>
<publisher-name>Department of Agriculture and Fisheries Biosecurity</publisher-name></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Salgado-Bierman</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rupnik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>van Coeverden de Groot</surname>
<given-names>P</given-names></string-name></person-group>. <year>2019</year>. <article-title>Clostridium (Clostridioides) difficile shedding by polar bears (Ursus maritimus) in the Canadian Arctic</article-title>. <source>Anaerobe</source>
<volume>57</volume>:<fpage>35</fpage>&#x02013;<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.anaerobe.2019.03.013</pub-id><pub-id pub-id-type="pmid">30880150</pub-id>
</mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bandelj</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Knapi&#x0010d;</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Rousseau</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Podgorelec</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Presetnik</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Vengust</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Scott Weese</surname>
<given-names>J</given-names></string-name></person-group>. <year>2019</year>. <article-title>Clostridioides difficile in bat guano</article-title>. <source>Comp Immunol Microbiol Infect Dis</source>
<volume>65</volume>:<fpage>144</fpage>&#x02013;<lpage>147</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cimid.2019.05.016</pub-id><pub-id pub-id-type="pmid">31300105</pub-id>
</mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Bandelj</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Blagus</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Briski</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Frlic</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Vergles Rataj</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Rupnik</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ocepek</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Vengust</surname>
<given-names>M</given-names></string-name></person-group>. <year>2016</year>. <article-title>Identification of risk factors influencing Clostridium difficile prevalence in middle-size dairy farms</article-title>. <source>Vet Res</source>
<volume>47</volume>:<elocation-id>41</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s13567-016-0326-0</pub-id><pub-id pub-id-type="pmid">26968527</pub-id>
</mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Ozaki</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Kato</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kita</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Karasawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Maegawa</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Koino</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Matsumoto</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Takada</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nomoto</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Tanaka</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Nakamura</surname>
<given-names>S</given-names></string-name></person-group>. <year>2004</year>. <article-title>Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization</article-title>. <source>J Med Microbiol</source>
<volume>53</volume>:<fpage>167</fpage>&#x02013;<lpage>172</lpage>. doi:<pub-id pub-id-type="doi">10.1099/jmm.0.05376-0</pub-id><pub-id pub-id-type="pmid">14729940</pub-id>
</mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Orenstein</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Patron</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Seville</surname>
<given-names>MT</given-names></string-name></person-group>. <year>2019</year>. <article-title>Why does Clostridium difficile infection recur?</article-title>
<source>J Am Osteopath Assoc</source>
<volume>119</volume>:<fpage>322</fpage>&#x02013;<lpage>326</lpage>. doi:<pub-id pub-id-type="doi">10.7556/jaoa.2019.054</pub-id><pub-id pub-id-type="pmid">31034070</pub-id>
</mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Thean</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Elliott</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2011</year>. <article-title>Clostridium difficile in horses in Australia &#x02013; a preliminary study</article-title>. <source>J Med Microbiol</source>
<volume>60</volume>:<fpage>1188</fpage>&#x02013;<lpage>1192</lpage>. doi:<pub-id pub-id-type="doi">10.1099/jmm.0.030908-0</pub-id><pub-id pub-id-type="pmid">21436371</pub-id>
</mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Staempfli</surname>
<given-names>HR</given-names></string-name>, <string-name><surname>Prescott</surname>
<given-names>JF</given-names></string-name></person-group>. <year>2001</year>. <article-title>A prospective study of the roles of Clostridium difficile and enterotoxigenic Clostridium perfringens in equine diarrhoea</article-title>. <source>Equine Vet J</source>
<volume>33</volume>:<fpage>403</fpage>&#x02013;<lpage>409</lpage>. doi:<pub-id pub-id-type="doi">10.2746/042516401776249534</pub-id><pub-id pub-id-type="pmid">11469775</pub-id>
</mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Shaughnessy</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Snider</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Sepulveda</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Boxrud</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Cebelinski</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Jawahir</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Holzbauer</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Johnston</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bender</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Thuras</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Diez-Gonzalez</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>JR</given-names></string-name></person-group>. <year>2018</year>. <article-title>Prevalence and molecular characteristics of Clostridium difficile in retail meats, food-producing and companion animals, and humans in minnesota</article-title>. <source>J Food Prot</source>
<volume>81</volume>:<fpage>1635</fpage>&#x02013;<lpage>1642</lpage>. doi:<pub-id pub-id-type="doi">10.4315/0362-028X.JFP-18-104</pub-id><pub-id pub-id-type="pmid">30198756</pub-id>
</mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Keel</surname>
<given-names>MK</given-names></string-name>, <string-name><surname>Songer</surname>
<given-names>JG</given-names></string-name></person-group>. <year>2006</year>. <article-title>The comparative pathology of Clostridium difficile-associated disease</article-title>. <source>Vet Pathol</source>
<volume>43</volume>:<fpage>225</fpage>&#x02013;<lpage>240</lpage>. doi:<pub-id pub-id-type="doi">10.1354/vp.43-3-225</pub-id><pub-id pub-id-type="pmid">16672570</pub-id>
</mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Schoster</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Staempfli</surname>
<given-names>HR</given-names></string-name></person-group>. <year>2016</year>. <article-title>Epidemiology and antimicrobial resistance in Clostridium difficile with special reference to the horse</article-title>. <source>Curr Clin Micro Rpt</source>
<volume>3</volume>:<fpage>32</fpage>&#x02013;<lpage>41</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40588-016-0029-3</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Slimings</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2014</year>. <article-title>Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis</article-title>. <source>J Antimicrob Chemother</source>
<volume>69</volume>:<fpage>881</fpage>&#x02013;<lpage>891</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkt477</pub-id><pub-id pub-id-type="pmid">24324224</pub-id>
</mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Kauter</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Epping</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Semmler</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Antao</surname>
<given-names>E-M</given-names></string-name>, <string-name><surname>Kannapin</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Stoeckle</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Gehlen</surname>
<given-names>H</given-names></string-name>, <string-name><surname>L&#x000fc;bke-Becker</surname>
<given-names>A</given-names></string-name>, <string-name><surname>G&#x000fc;nther</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wieler</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Walther</surname>
<given-names>B</given-names></string-name></person-group>. <year>2019</year>. <article-title>The gut microbiome of horses: current research on equine enteral microbiota and future perspectives</article-title>. <source>Anim Microbiome</source>
<volume>1</volume>:<elocation-id>14</elocation-id>. doi:<pub-id pub-id-type="doi">10.1186/s42523-019-0013-3</pub-id><pub-id pub-id-type="pmid">33499951</pub-id>
</mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Den&#x000e8;ve</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Delom&#x000e9;nie</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Barc</surname>
<given-names>M-C</given-names></string-name>, <string-name><surname>Collignon</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Janoir</surname>
<given-names>C</given-names></string-name></person-group>. <year>2008</year>. <article-title>Antibiotics involved in Clostridium difficile-associated disease increase colonization factor gene expression</article-title>. <source>J Med Microbiol</source>
<volume>57</volume>:<fpage>732</fpage>&#x02013;<lpage>738</lpage>. doi:<pub-id pub-id-type="doi">10.1099/jmm.0.47676-0</pub-id><pub-id pub-id-type="pmid">18480330</pub-id>
</mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Drummond</surname>
<given-names>LJ</given-names></string-name>, <string-name><surname>Smith</surname>
<given-names>DGE</given-names></string-name>, <string-name><surname>Poxton</surname>
<given-names>IR</given-names></string-name></person-group>. <year>2003</year>. <article-title>Effects of sub-MIC concentrations of antibiotics on growth of and toxin production by Clostridium difficile</article-title>. <source>J Med Microbiol</source>
<volume>52</volume>:<fpage>1033</fpage>&#x02013;<lpage>1038</lpage>. doi:<pub-id pub-id-type="doi">10.1099/jmm.0.05387-0</pub-id><pub-id pub-id-type="pmid">14614060</pub-id>
</mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Magistrali</surname>
<given-names>CF</given-names></string-name>, <string-name><surname>Maresca</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Cucco</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bano</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Drigo</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Filippini</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Dettori</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Broccatelli</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pezzotti</surname>
<given-names>G</given-names></string-name></person-group>. <year>2015</year>. <article-title>Prevalence and risk factors associated with Clostridium difficile shedding in veal calves in Italy</article-title>. <source>Anaerobe</source>
<volume>33</volume>:<fpage>42</fpage>&#x02013;<lpage>47</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.anaerobe.2015.01.010</pub-id><pub-id pub-id-type="pmid">25638401</pub-id>
</mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Rodriguez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Taminiau</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Br&#x000e9;vers</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Avesani</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Van Broeck</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Leroux</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Amory</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Delm&#x000e9;e</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Daube</surname>
<given-names>G</given-names></string-name></person-group>. <year>2014</year>. <article-title>Carriage and acquisition rates of Clostridium difficile in hospitalized horses, including molecular characterization, multilocus sequence typing and antimicrobial susceptibility of bacterial isolates</article-title>. <source>Vet Microbiol</source>
<volume>172</volume>:<fpage>309</fpage>&#x02013;<lpage>317</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2014.05.013</pub-id><pub-id pub-id-type="pmid">24894133</pub-id>
</mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Harlow</surname>
<given-names>BE</given-names></string-name>, <string-name><surname>Lawrence</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Flythe</surname>
<given-names>MD</given-names></string-name></person-group>. <year>2013</year>. <article-title>Diarrhea-associated pathogens, lactobacilli and cellulolytic bacteria in equine feces: responses to antibiotic challenge</article-title>. <source>Vet Microbiol</source>
<volume>166</volume>:<fpage>225</fpage>&#x02013;<lpage>232</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2013.05.003</pub-id><pub-id pub-id-type="pmid">23769300</pub-id>
</mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Richards</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bailey</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Scarborough</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gilkerson</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Browning</surname>
<given-names>GF</given-names></string-name>, <string-name><surname>Hur</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Ierardo</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Awad</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Chay</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Hardefeldt</surname>
<given-names>LY</given-names></string-name></person-group>. <year>2024</year>. <article-title>Cross-sectional evaluation of a large-scale antimicrobial stewardship trial in Australian companion animal practices</article-title>. <source>Vet Rec</source>
<volume>194</volume>:<elocation-id>e3268</elocation-id>. doi:<pub-id pub-id-type="doi">10.1002/vetr.3268</pub-id><pub-id pub-id-type="pmid">37518680</pub-id>
</mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Hardefeldt</surname>
<given-names>LY</given-names></string-name>, <string-name><surname>Gilkerson</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Billman-Jacobe</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Stevenson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Thursky</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Bailey</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Browning</surname>
<given-names>GF</given-names></string-name></person-group>. <year>2018</year>. <article-title>Barriers to and enablers of implementing antimicrobial stewardship programs in veterinary practices</article-title>. <source>J Vet Intern Med</source>
<volume>32</volume>:<fpage>1092</fpage>&#x02013;<lpage>1099</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jvim.15083</pub-id><pub-id pub-id-type="pmid">29573053</pub-id>
</mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Medina-Torres</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Staempfli</surname>
<given-names>HR</given-names></string-name></person-group>. <year>2011</year>. <article-title>Prevalence of Clostridium difficile in horses</article-title>. <source>Vet Microbiol</source>
<volume>152</volume>:<fpage>212</fpage>&#x02013;<lpage>215</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.vetmic.2011.04.012</pub-id><pub-id pub-id-type="pmid">21570780</pub-id>
</mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Knight</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Squire</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2015</year>. <article-title>Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes</article-title>. <source>Appl Environ Microbiol</source>
<volume>81</volume>:<fpage>119</fpage>&#x02013;<lpage>123</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AEM.03032-14</pub-id><pub-id pub-id-type="pmid">25326297</pub-id>
</mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Brouwer</surname>
<given-names>MSM</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Hussain</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Williams</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Allan</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mullany</surname>
<given-names>P</given-names></string-name></person-group>. <year>2013</year>. <article-title>Horizontal gene transfer converts non-toxigenic Clostridium difficile strains into toxin producers</article-title>. <source>Nat Commun</source>
<volume>4</volume>:<elocation-id>2601</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/ncomms3601</pub-id><pub-id pub-id-type="pmid">24131955</pub-id>
</mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Elliott</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Dingle</surname>
<given-names>KE</given-names></string-name>, <string-name><surname>Didelot</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Crook</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2014</year>. <article-title>The complexity and diversity of the pathogenicity locus in Clostridium difficile clade 5</article-title>. <source>Genome Biol Evol</source>
<volume>6</volume>:<fpage>3159</fpage>&#x02013;<lpage>3170</lpage>. doi:<pub-id pub-id-type="doi">10.1093/gbe/evu248</pub-id><pub-id pub-id-type="pmid">25381663</pub-id>
</mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Candel-P&#x000e9;rez</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Ros-Berruezo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Mart&#x000ed;nez-Graci&#x000e1;</surname>
<given-names>C</given-names></string-name></person-group>. <year>2019</year>. <article-title>A review of Clostridioides [Clostridium] difficile occurrence through the food chain</article-title>. <source>Food Microbiol</source>
<volume>77</volume>:<fpage>118</fpage>&#x02013;<lpage>129</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.fm.2018.08.012</pub-id><pub-id pub-id-type="pmid">30297042</pub-id>
</mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>He</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Miyajima</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Roberts</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ellison</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pickard</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Connor</surname>
<given-names>TR</given-names></string-name>, <string-name><surname>Harris</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Fairley</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Bamford</surname>
<given-names>KB</given-names></string-name>, <etal>et al.</etal></person-group>. <year>2013</year>. <article-title>Emergence and global spread of epidemic healthcare-associated Clostridium difficile</article-title>. <source>Nat Genet</source>
<volume>45</volume>:<fpage>109</fpage>&#x02013;<lpage>113</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2478</pub-id><pub-id pub-id-type="pmid">23222960</pub-id>
</mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Marvaud</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Quevedo-Torres</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Janoir</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Barbut</surname>
<given-names>F</given-names></string-name></person-group>. <year>2019</year>. <article-title>Virulence of new variant strains of Clostridium difficile producing only toxin A or binary toxin in the hamster model</article-title>. <source>New Microbes New Infect</source>
<volume>32</volume>:<elocation-id>100590</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.nmni.2019.100590</pub-id><pub-id pub-id-type="pmid">31516714</pub-id>
</mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Monot</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Eckert</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Lemire</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Hamiot</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Dubois</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Tessier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Dumoulard</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Hamel</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Petit</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Lalande</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Bouchier</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Barbut</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Dupuy</surname>
<given-names>B</given-names></string-name></person-group>. <year>2015</year>. <article-title>Clostridium difficile: new insights into the evolution of the pathogenicity locus</article-title>. <source>Sci Rep</source>
<volume>5</volume>:<elocation-id>15023</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/srep15023</pub-id><pub-id pub-id-type="pmid">26446480</pub-id>
</mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Keessen</surname>
<given-names>EC</given-names></string-name>, <string-name><surname>Hopman</surname>
<given-names>NEM</given-names></string-name>, <string-name><surname>van Leengoed</surname>
<given-names>LAMG</given-names></string-name>, <string-name><surname>van Asten</surname>
<given-names>AJAM</given-names></string-name>, <string-name><surname>Hermanus</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Kuijper</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Lipman</surname>
<given-names>LJA</given-names></string-name></person-group>. <year>2011</year>. <article-title>Evaluation of four different diagnostic tests to detect Clostridium difficile in piglets</article-title>. <source>J Clin Microbiol</source>
<volume>49</volume>:<fpage>1816</fpage>&#x02013;<lpage>1821</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.00242-11</pub-id><pub-id pub-id-type="pmid">21411571</pub-id>
</mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Fathy</surname>
<given-names>M</given-names></string-name>, <string-name><surname>A. Abdel-Moein</surname>
<given-names>K</given-names></string-name>, <string-name><surname>A. Osman</surname>
<given-names>W</given-names></string-name>, <string-name><surname>M. Erfan</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Prince</surname>
<given-names>A</given-names></string-name>, <string-name><surname>A. Hafez</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Eldin Mahmoud</surname>
<given-names>H</given-names></string-name>, <string-name><surname>E. Mosallam</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Samir</surname>
<given-names>A</given-names></string-name></person-group>. <year>2020</year>. <article-title>Performance of different laboratory methods for detection of Clostridium difficile in animal samples</article-title>. <source>Adv Anim Vet Sci</source>
<volume>9</volume>:<fpage>132</fpage>&#x02013;<lpage>136</lpage>. doi:<pub-id pub-id-type="doi">10.17582/journal.aavs/2021/9.1.132.136</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>McDonald</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Gerding</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Bakken</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Carroll</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Coffin</surname>
<given-names>SE</given-names></string-name>, <string-name><surname>Dubberke</surname>
<given-names>ER</given-names></string-name>, <string-name><surname>Garey</surname>
<given-names>KW</given-names></string-name>, <string-name><surname>Gould</surname>
<given-names>CV</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Loo</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Shaklee Sammons</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Sandora</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Wilcox</surname>
<given-names>MH</given-names></string-name></person-group>. <year>2018</year>. <article-title>Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 Update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)</article-title>. <source>Clin Infect Dis</source>
<volume>66</volume>:<fpage>e1</fpage>&#x02013;<lpage>e48</lpage>. doi:<pub-id pub-id-type="doi">10.1093/cid/cix1085</pub-id><pub-id pub-id-type="pmid">29462280</pub-id>
</mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Zakia</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Arroyo</surname>
<given-names>LG</given-names></string-name>, <string-name><surname>Gomez</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Boerlin</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Surette</surname>
<given-names>MG</given-names></string-name>, <string-name><surname>Lillie</surname>
<given-names>BN</given-names></string-name></person-group>. <year>2023</year>. <article-title>Postmortem examination of equids &#x0003e;1-year-old with enterotyphlocolitis in Ontario: a retrospective descriptive study</article-title>. <source>J Vet Diagn Invest</source>
<volume>35</volume>:<fpage>350</fpage>&#x02013;<lpage>354</lpage>. doi:<pub-id pub-id-type="doi">10.1177/10406387231176229</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Medina-Torres</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Weese</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Staempfli</surname>
<given-names>HR</given-names></string-name></person-group>. <year>2010</year>. <article-title>Validation of a commercial enzyme immunoassay for detection of Clostridium difficile toxins in feces of horses with acute diarrhea</article-title>. <source>J Vet Intern Med</source>
<volume>24</volume>:<fpage>628</fpage>&#x02013;<lpage>632</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1939-1676.2010.00506.x</pub-id><pub-id pub-id-type="pmid">20384955</pub-id>
</mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Moono</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Lim</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2017</year>. <article-title>High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia</article-title>. <source>Sci Rep</source>
<volume>7</volume>:<elocation-id>41196</elocation-id>. doi:<pub-id pub-id-type="doi">10.1038/srep41196</pub-id><pub-id pub-id-type="pmid">28145453</pub-id>
</mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lim</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Androga</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>Knight</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Moono</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Foster</surname>
<given-names>NF</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2018</year>. <article-title>Antimicrobial susceptibility of Clostridium difficile isolated from food and environmental sources in Western Australia</article-title>. <source>Int J Antimicrob Agents</source>
<volume>52</volume>:<fpage>411</fpage>&#x02013;<lpage>415</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2018.05.013</pub-id><pub-id pub-id-type="pmid">29802886</pub-id>
</mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="patent">
<person-group person-group-type="author"><string-name><surname>Cellier</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Halimi</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Orenga</surname>
<given-names>S</given-names></string-name></person-group>. <year>2013</year>. <article-title>Use of a beta-glucosidase activator for the detection and/or identification of C. difficile</article-title>. <patent>US patent 20130137126 A1</patent>, <comment>issued</comment></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Connor</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Fairley</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>McKenna</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Marks</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>McGrath</surname>
<given-names>JW</given-names></string-name></person-group>. <year>2016</year>. <article-title>Clostridium difficile ribotype 023 lacks the ability to hydrolyze esculin, leading to false-negative results on chromogenic agar</article-title>. <source>J Clin Microbiol</source>
<volume>54</volume>:<fpage>1404</fpage>&#x02013;<lpage>1405</lpage>. doi:<pub-id pub-id-type="doi">10.1128/JCM.00234-16</pub-id><pub-id pub-id-type="pmid">26962090</pub-id>
</mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Reigadas</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Alcal&#x000e1;</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Mar&#x000ed;n</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Mart&#x000ed;n</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bouza</surname>
<given-names>E</given-names></string-name></person-group>. <year>2017</year>. <article-title>C. difficile PCR-ribotype 023 might go undetected when using chromId C. difficile agar</article-title>. <source>Anaerobe</source>
<volume>44</volume>:<fpage>34</fpage>&#x02013;<lpage>35</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.anaerobe.2017.01.008</pub-id><pub-id pub-id-type="pmid">28108388</pub-id>
</mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Shivaperumal</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Knight</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Imwattana</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Androga</surname>
<given-names>GO</given-names></string-name>, <string-name><surname>Chang</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2022</year>. <article-title>Esculin hydrolysis negative and TcdA-only producing strains of Clostridium (Clostridioides) difficile from the environment in Western Australia</article-title>. <source>J Appl Microbiol</source>
<volume>133</volume>:<fpage>1183</fpage>&#x02013;<lpage>1196</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jam.15500</pub-id><pub-id pub-id-type="pmid">35184359</pub-id>
</mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Wickramage</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Spigaglia</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>X</given-names></string-name></person-group>. <year>2021</year>. <article-title>Mechanisms of antibiotic resistance of Clostridioides difficile</article-title>. <source>J Antimicrob Chemother</source>
<volume>76</volume>:<fpage>3077</fpage>&#x02013;<lpage>3090</lpage>. doi:<pub-id pub-id-type="doi">10.1093/jac/dkab231</pub-id><pub-id pub-id-type="pmid">34297842</pub-id>
</mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Centers for Disease Control and Prevention</collab></person-group>. <year>2019</year>. <article-title>Antibiotic resistance threats in the United States</article-title>. <publisher-name>U.S. Department of Health and Human Services, Centers for Disease Control and Prevention</publisher-name>. <comment>Available from</comment>: <pub-id pub-id-type="doi">10.15620/cdc:82532</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Harvey</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Meggiolaro</surname>
<given-names>MN</given-names></string-name>, <string-name><surname>Hall</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Watts</surname>
<given-names>ET</given-names></string-name>, <string-name><surname>Ramp</surname>
<given-names>D</given-names></string-name>, <string-name><surname>&#x00160;lapeta</surname>
<given-names>J</given-names></string-name></person-group>. <year>2019</year>. <article-title>Wild horse populations in south-east Australia have a high prevalence of Strongylus vulgaris and may act as a reservoir of infection for domestic horses</article-title>. <source>Int J Parasitol Parasites Wildl</source>
<volume>8</volume>:<fpage>156</fpage>&#x02013;<lpage>163</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijppaw.2019.01.008</pub-id><pub-id pub-id-type="pmid">30815358</pub-id>
</mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>Lim</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Foster</surname>
<given-names>NF</given-names></string-name>, <string-name><surname>Elliott</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Riley</surname>
<given-names>TV</given-names></string-name></person-group>. <year>2018</year>. <article-title>High prevalence of Clostridium difficile on retail root vegetables, Western Australia</article-title>. <source>J Appl Microbiol</source>
<volume>124</volume>:<fpage>585</fpage>&#x02013;<lpage>590</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jam.13653</pub-id><pub-id pub-id-type="pmid">29193458</pub-id>
</mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Clinical and Laboratory Standards Institute</collab></person-group>. <year>2011</year>. <source>Methods for antimicrobial susceptibility testing of anaerobic bacteria</source>. <edition>7th</edition> ed. <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>, <publisher-loc>Wayne, PA</publisher-loc>.</mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="webpage">
<person-group person-group-type="author"><collab>The European Committee on Antimicrobial Susceptibility Testing</collab></person-group>. <year>2023</year>. <article-title>Breakpoint tables for interpretation of MICs and zone diameters, Version 13.0</article-title>. <comment>Available from</comment>: <ext-link xlink:href="http://www.eucast.org" ext-link-type="uri">http://www.eucast.org</ext-link></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>European Medicines Agency</collab></person-group>. <year>2011</year>. <article-title>Assessment report, Dificlir fidaxomicin EMA/857570/2011</article-title>. <publisher-name>EMA, European Union</publisher-name>. <ext-link xlink:href="https://www.ema.europa.eu" ext-link-type="uri">https://www.ema.europa.eu</ext-link>.</mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><string-name><surname>O&#x02019;Connor</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Galang</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Sambol</surname>
<given-names>SP</given-names></string-name>, <string-name><surname>Hecht</surname>
<given-names>DW</given-names></string-name>, <string-name><surname>Vedantam</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Gerding</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Johnson</surname>
<given-names>S</given-names></string-name></person-group>. <year>2008</year>. <article-title>Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile</article-title>. <source>Antimicrob Agents Chemother</source>
<volume>52</volume>:<fpage>2813</fpage>&#x02013;<lpage>2817</lpage>. doi:<pub-id pub-id-type="doi">10.1128/AAC.00342-08</pub-id><pub-id pub-id-type="pmid">18559647</pub-id>
</mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><collab>Clinical and Laboratory Standards Institute</collab></person-group>. <year>2013</year>. <source>M100-S23</source>. <source>Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement</source>. <publisher-name>Clinical and Laboratory Standards Institute</publisher-name>, <publisher-loc>Wayne, PA</publisher-loc>.</mixed-citation></ref></ref-list></back></article>